The Potential of Mesenchymal Stromal Stem Cells to Correct Immune and Metabolic Dysfunctions in Circulating Immune Cells During Sepsis: An Ex Vivo Pilot Study.

by | Sep 20, 2026 | Clinical Trials | 0 comments

​ Conditions: Sepsis

Interventions: Biological: Blood sample; Biological: Blood sample

Sponsors: Centre Hospitalier Universitaire Dijon

Not yet recruiting Conditions: Sepsis
Interventions: Biological: Blood sample; Biological: Blood sample
Sponsors: Centre Hospitalier Universitaire Dijon
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *